NCT04357925

Brief Summary

Recording cancer data in cancer registries is essential for producing reliable population-based data for service planning, monitoring and evaluation. Prostate cancer (PCa) remains the most frequent type of cancer in terms of incidence and mortality in men in the Caribbean. The quality of life PCa cohort will assess quality of life and patient outcomes in Martinique using a digital platform for patient-reported outcome measures.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for all trials

Timeline
32mo left

Started May 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
May 2020Dec 2028

First Submitted

Initial submission to the registry

April 17, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2020

Completed
14 days until next milestone

Study Start

First participant enrolled

May 6, 2020

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

7.7 years

First QC Date

April 17, 2020

Last Update Submit

March 26, 2026

Conditions

Prostate Cancer

Keywords

ProstatePublic HealthQuality of life

Outcome Measures

Primary Outcomes (2)

  • Evaluation of overall Quality of Life: Questionnaire

    Change of quality of life questionnaire related to sexual dysfunction

    At the date of diagnosis of the disease, at 1 year, 3 years and 5 years

  • Evaluation of overall Quality of Life: Questionnaire

    Change of quality of life questionnaire related to urinary troubles

    At the date of diagnosis of the disease, at 1 year, 3 years and 5 years

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with prostate cancer diagnosed in Martinique in differents units care.

You may qualify if:

  • Age\>18 years and residing in Martinique, with prostate cancer diagnosed from 2020
  • The patient has provided informed consent
  • Patient with social security coverage

You may not qualify if:

  • Refusal to participate
  • Patient with a second cancer, five years after diagnosis
  • Patient who could not answer the quality of life questionnaires
  • Patient not fluent in French
  • Person under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Martinique

Fort-de-France, Martinique

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • Clarisse CONTARET-JOACHIM

    CHU Martinique

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2020

First Posted

April 22, 2020

Study Start

May 6, 2020

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

March 31, 2026

Record last verified: 2026-03

Locations

MA(1)